SCHEMBL31078985

SCHEMBL31078985

CC(C)(C)OC(=O)N1CCC1(C)C(N)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 1/20 0.40
GRIN2C Q14957 1/20 0.40
USP2 O75604 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CTSK P43235 1/20 0.35
KDM1A O60341 1/20 0.35
HPGD P15428 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
EPHX2 P34913 1/20 0.33
GPR119 Q8TDV5 1/20 0.33
JAK3 P52333 1/20 0.32
BUB1 O43683 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
NR1H2 P55055 1/20 0.32
RECQL P46063 1/20 0.32
EPHX1 P07099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31105397 1.00 GRIN2B (0.40) GRIN2BGRIN2CUSP2SMN1; SMN2CTSK
SCHEMBL6632443 0.90 GRIN2B (0.46) GRIN2BGRIN2CUSP2SMN1; SMN2CTSK
SCHEMBL14234512 0.90 GRIN2B (0.46) GRIN2BGRIN2CUSP2SMN1; SMN2CTSK
SCHEMBL15125135 0.90 GRIN2B (0.46) GRIN2BGRIN2CUSP2SMN1; SMN2CTSK
SCHEMBL20054323 0.89 GRIN2B (0.43) GRIN2BGRIN2CUSP2SMN1; SMN2CTSK
SCHEMBL11954515 0.85 USP2 (0.38) GRIN2BGRIN2CUSP2SMN1; SMN2CTSK
SCHEMBL11954522 0.85 USP2 (0.38) GRIN2BGRIN2CUSP2SMN1; SMN2CTSK
SCHEMBL31078891 0.85 USP2 (0.38) GRIN2BGRIN2CUSP2SMN1; SMN2CTSK
SCHEMBL6078246 0.84 USP2 (0.40) GRIN2BGRIN2CUSP2SMN1; SMN2CTSK
SCHEMBL7227763 0.84 USP2 (0.40) GRIN2BGRIN2CUSP2SMN1; SMN2CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651872-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE TO TREAT HYPOPARATHYROIDISM AND OSTEOPOROSIS Septerna, Inc. (US) 2025-11-26 EP disclosed
WO-2024155601-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE TO TREAT HYPOPARATHYROIDISM AND OSTEOPOROSIS SEPTERNA, INC. (US) 2024-07-25 WO disclosed